We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
VeriSign
VRSN
$26.6B
| $202M | 0.46% |
1,702,845
-46,158
| -3% | -$5.35M |
|
52
HP
HPQ
$27.5B
| $200M | 0.46% |
9,127,389
-3,707,632
| -29% | -$83.7M |
|
53
S&P Global
SPGI
$120B
| $199M | 0.46% |
1,041,544
+181,925
| +21% | +$33.6M |
|
54
NVIDIA
NVDA
$5.42T
| $198M | 0.45% |
+34,221,280
| New | +$201M |
|
55
Microsoft
MSFT
$3.71T
| $198M | 0.45% |
2,170,400
+2,114,900
| +3,811% | +$193M |
|
56
Northrop Grumman
NOC
$81.2B
| $198M | 0.45% |
566,919
-215,111
| -28% | -$72.1M |
|
57
Moody's
MCO
$82.7B
| $192M | 0.44% |
1,193,288
+996,384
| +506% | +$161M |
|
58
Elevance Health
ELV
$85.5B
| $188M | 0.43% |
855,577
-904,179
| -51% | -$212M |
|
59
Colgate-Palmolive
CL
$74.4B
| $187M | 0.43% |
2,611,647
-943,228
| -27% | -$67.9M |
|
60
Thomson Reuters
TRI
$44.1B
| $186M | 0.43% |
4,143,276
+3,798,252
| +1,101% | +$182M |
|
61
Alphabet (Google) Class C
GOOG
$4.32T
| $183M | 0.42% |
3,551,160
-3,690,740
| -51% | -$204M |
|
62
Eli Lilly
LLY
$1.06T
| $181M | 0.41% |
2,334,294
+1,214,407
| +108% | +$97.8M |
|
63
Public Storage
PSA
$61.3B
| $173M | 0.4% |
865,330
+166,031
| +24% | +$32.3M |
|
|
BNY
64
Bank of New York Mellon
BNY
$107B
| $172M | 0.4% |
3,341,526
-210,109
| -6% | -$11.7M |
|
65
eBay
EBAY
$49.8B
| $171M | 0.39% |
4,247,486
+1,408,953
| +50% | +$58.3M |
|
66
Union Pacific
UNP
$174B
| $169M | 0.39% |
1,256,903
-686,139
| -35% | -$92.3M |
|
67
Ferrari
RACE
$72.5B
| $169M | 0.39% |
1,403,357
-834,837
| -37% | -$101M |
|
68
Yum! Brands
YUM
$41.1B
| $168M | 0.38% |
1,970,085
+733,407
| +59% | +$60.1M |
|
69
Scotiabank
BNS
$108B
| $162M | 0.37% |
+2,628,971
| New | +$167M |
|
70
Dollar General
DG
$27.9B
| $159M | 0.36% |
1,698,469
+1,395,467
| +461% | +$134M |
|
71
Lowe's Companies
LOW
$125B
| $158M | 0.36% |
1,800,482
-479,259
| -21% | -$45.4M |
|
|
CERN
72
DELISTED
Cerner Corp
CERN
| $155M | 0.36% |
2,677,213
+1,788,225
| +201% | +$116M |
|
73
Monster Beverage
MNST
$88.5B
| $154M | 0.35% |
5,393,462
+2,720,076
| +102% | +$84.9M |
|
74
iShares MSCI EAFE ETF
EFA
$80.2B
| $149M | 0.34% |
2,140,066
+201,562
| +10% | +$14.4M |
|
75
Estee Lauder
EL
$32B
| $149M | 0.34% |
992,073
+464,412
| +88% | +$64.3M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.